Lantid 30 mg (Capsule (Enteric Coated))

Unit Price: ৳ 5.02 (3 x 6: ৳ 90.36)
Strip Price: ৳ 30.12

Medicine Details

Category Details
Generic Lansoprazole
Company Opsonin pharma ltd

Indications

  • Short-term treatment of active duodenal ulcer
  • Maintenance of healed duodenal ulcers
  • Short-term treatment of active benign gastric ulcers
  • Short-term treatment of active erosive esophagitis
  • Maintenance of healing of erosive esophagitis
  • Pathological hypersecretory conditions including Zollinger-Ellison Syndrome
  • H. pylori eradication to reduce the risk of duodenal ulcer recurrence

Pharmacology

Lansoprazole is a substituted benzimidazole, and is also known as PPI due to its property to block the final step of acid secretion by inhibiting H+/K+ ATPase enzyme system in gastric parietal cell. Both basal and stimulated acid are inhibited.

Dosage & Administration

  • 30 mg daily in the morning for benign gastric ulcer for 8 weeks
  • 30 mg daily in the morning for duodenal ulcer for 4 weeks; maintenance 15 mg
  • 15-30 mg daily for NSAID-associated duodenal or gastric ulcer
  • Initially 60 mg once daily for Zollinger-Ellison syndrome; adjusted according to response
  • 30 mg daily in the morning for gastroesophageal reflux disease for 4 weeks
  • 15-30 mg daily in the morning for acid-related dyspepsia for 2-4 weeks

Interaction

Lantid appears to be a selective inhibitor of the cytochrome P-450 monooxygenase system; there may be an effect on hepatic clearance, but there have been no reports to date of clinically relevant interactions. There is some uncertainty over the effect of Lantid on the oral combined contraceptive pill. Physiological changes similar to those found with omeprazole are likely to occur due to the reduction in gastric acid, which may influence the bacterial colonization of the stomach and duodenum and vitamin B12 absorption.

Contraindications

Lansoprazole is contraindicated in patients with known hypersensitivity to any component of the formulation.

Side Effects

  • Possible induction of carcinoid tumors by profound acid suppression
  • Rise in serum gastrin levels
  • Long-term treatment may accelerate the development of atrophic gastritis
  • Dose dependent diarrhea
  • Headache

Pregnancy & Lactation

Lansoprazole should be avoided in pregnancy unless there are compelling reasons.

Precautions & Warnings

  • Gastric malignancy should be ruled out
  • Hepatic impairment
  • Pregnancy and lactation

Use in Special Populations

  • Neonates: Not recommended
  • Children: The youngest person to have received Lantid in clinical trials was 13 years old
  • The Elderly: No increase in adverse drug reaction

Therapeutic Class

Proton Pump Inhibitor

Storage Conditions

Store at 25°C

Related Brands